Neutral Red Assay Kit - Cell Viability / Cytotoxicity (ab234039)
Key features and details
- Assay type: Cell-based (quantitative)
- Detection method: Colorimetric
- Platform: Microplate reader
- Sample type: Adherent cells, Suspension cells
Overview
-
Product name
Neutral Red Assay Kit - Cell Viability / Cytotoxicity -
Detection method
Colorimetric -
Sample type
Adherent cells, Suspension cells -
Assay type
Cell-based (quantitative) -
Product overview
Neutral Red Assay Kit - Cell Viability/Cytotoxicity (ab234039) is simple, accurate and reproducible. This kit offers an excellent and efficient method for in vitro cytotoxicity studies as well as high-throughput drug screening that can detect between 5,000-50,000 cells per well. It includes Doxorubicin as a positive control.
Neutral red cell cytotoxicity assay is one of the common methods used to detect cell viability or drug cytotoxicity. The principle of this assay is based on the detection of viable cells via the uptake of the dye neutral red. Neutral red is a eurhodin dye that stains lysosomes in viable cells. Viable cells can take up neutral red via active transport and incorporate the dye into their lysosomes but non-viable cells cannot not take up this chromophore. Consequently, after washing, viable cells can release the incorporated dye in under acidifiedextracted conditions. The amount of released dye can be used to determine the total number of viable cells or drug cytotoxicity. The neutral red uptake assay provides a quantitative measurement of the number of viable cells and can be measured at OD 540 nm.
-
Platform
Microplate reader
Properties
-
Storage instructions
Store at -20°C. Please refer to protocols. -
Components 1000 tests 100X Neutral Red Staining Solution 1 x 2ml 10X Washing Solution 1 x 70ml 20 mM Doxorubicin 1 x 100µl 2X Solubilization Solution 1 x 75ml
Images
-
Dose-response curve of HepG2 (human liver hepatocellular carcinoma cell line) cells treated with doxorubicin for 72 hours determined using the Neutral Red Assay Kit - Cell Viability / Cytotoxicity (ab234039). Assays were performed according to the kit protocol in triplicate.
-
Dose-response curve of MCF7 (human breast adenocarcinoma cell line) cells treated with doxorubicin for 72 hours determined using the Neutral Red Assay Kit - Cell Viability / Cytotoxicity (ab234039). Assays were performed according to the kit protocol in triplicate.